March 29, 2024
The Ministry of Health, Labor and Welfare (MHLW) on March 28 ordered label revisions for four CAR-T cell therapy products including Gilead Sciences’ Yescarta (axicabtagene ciloleucel) to flag a new safety risk. The updated labels of the four CAR-T products...read more